$GM

GM Maintained by UBS -- Price Target Raised to $114

UBS maintained a 'Buy' rating on General Motors (GM) and raised its price target to $114 from $102. GM is seen as overvalued by 30.6% with a GF Value of $66.73. The company has a GF Score of 77/100, indicating solid performance. 17 gurus hold GM stock, with mixed activity. GM's P/E ratio is 40.35x, higher than its 5-year median of 6.57x.

Original reporting
Published Sep 14, 2026, 8:58 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 14, 2026, 9:31 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$GM
Bullish
medium confidence
Mentioned
$GM
Relevance
7/10
AlphAI data visualization · based on gurufocus.com
Decision brief

The 30-second read

$GMBullishMed
01

Why it matters

UBS's target increase signals confidence but valuation concerns remain.

02

Market read

Analyst target raise may influence short-term trading and sector sentiment.

03

What to watch

Insider selling and high P/E ratio could temper upside.

Relevance 7/10Novelty 6/10Timing: September 14, 2026

Background

GM is a large U.S. automaker with ongoing EV and autonomous vehicle initiatives.

Company-level read

Ticker impact

$GMBullishMedium confidence
Context

UBS maintained a Buy rating on GM and raised its price target to $114 from $102.

Expected impact

Potential price appreciation toward the new $114 target.

Evidence & confidence

Target raise reflects confidence in GM's EV and autonomous vehicle progress.

Market effects

May boost sentiment for the broader automotive and EV sector.

U.S. auto stocks could see modest gains.

Limited to investors tracking major US manufacturers.

Counterpoint

Some analysts may view the target raise as overly optimistic given GM's valuation.

Key entities

  • General Motors

    U.S. automaker subject of the analyst rating update.

  • UBS

    Raised GM price target to $114.

Related articles

$GMMedAI 8/10

GM bets on homegrown battery technology

GM is developing sodium-ion battery cells with Peak Energy to reduce reliance on Chinese materials like lithium. Commercial production is expected by 2029. GM is investing $900M in battery labs and aims to prioritize domestic production for EVs. China dominates global battery material production, per the IEA.

$GMMedAI 8/10

GM pursues domestic battery supply chain as Ford faces China scrutiny

GM aims to develop a domestic battery supply chain within 2-3 years, focusing on sodium-ion cells with Denver-based Peak Energy. The company is investing $900M in battery research facilities, targeting commercial production by 2029. GM's approach contrasts with Ford's use of Chinese battery technology, which has drawn scrutiny from the Trump administration.